San Francisco, CA USA
October 10-11, 2018


Webinar Series

A New Gentle Model of Neuropathic Pain 
Mary Hannaman, MD, President and Founder, Neurodigm

By using the new biomimetic model of neuropathic pain, your preclinical program can replace the Chung model, discover how opiates act over time and explore targeted biologics.

CLICK HERE to view the replay.

Press Releases

August 18, 2017 

Lotus Clinical Research Executive to Present on Opioid Sparing Endpoints at 11th Annual Pain & Migraine Therapeutics Summit

One of the biggest opportunities to reduce the dependency on opioids in pain management is the practice of opioid-dose sparing. Opioid-dose sparing refers to the reduction of opioid dosage by combining with a non-opioid. This practice has shown promising results, including with non-steroidal anti-inflammatory drugs (NSAIDs). 

July 14, 2017

New Clinical Trial Data for Novel Clinical-Stage Therapies for Pain to be Shared at Annual Pain and Migraine Therapeutics Summit

As the US and the rest of the world continue to grapple with the growing opioid crisis, the biopharmaceutical industry and leading academic researchers around the world continue to conduct ground-breaking research aimed at bringing safe, novel therapies to pain patients.

June 13, 2017

Preliminary Speaking Faculty for Arrowhead Publishers’ 11th Annual Pain and Migraine Therapeutics Summit

Arrowhead Publishers has just announced the preliminary speaking faculty for this year’s annual Pain and Migraine Therapeutics Summit, which will take place September 27-28, 2017 in San Diego, CA. 

April 24, 2017

Arrowhead Publishers' 11th Annual Pain and Migraine Therapeutics Summit Set to Take Place This Fall in San Diego, CA

Arrowhead Publishers is pleased to announce the 11th Annual Pain and Migraine Therapeutics Summit ( is coming to San Diego, CA on September 27-28, 2017. 

August 1, 2016

Research on an fMRI-Based Neurologic Signature of Physical Pain to be Presented at Upcoming 10th Annual Pain & Migraine Therapeutics Summit
As persistent pain is solely measured by self-report, research is currently being conducted to find objective methods of identifying physical pain in the brain. Researcher teams from various universities have discovered an imaging-based signature to predict pain sensitivity using functional magnetic resonance imaging (fMRI) and machine learning. 

About Us

Arrowhead Publishers' conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 

Contact Us

For general information about the conference, please contact us at:
 This email address is being protected from spambots. You need JavaScript enabled to view it.
  PO Box 96, Chanhassen, MN 55317 USA


Join Our Mailing List
Please fill out the following form in order to receive occasional updates regarding this conference, including updates regarding the agenda, speaker additions and conference promotions and DISCOUNTS.
We never share your personal data with anyone else, EVER!